|
US4657902A
(en)
|
1985-03-25 |
1987-04-14 |
The Rockefeller University |
Therapeutic use of tin mesoporphyrin
|
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5010073A
(en)
|
1989-10-05 |
1991-04-23 |
The Rockefeller University |
Use of liposomes as carriers for metalloporphyrins
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
WO1991018088A1
(en)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Adeno-associated virus (aav)-based eucaryotic vectors
|
|
US5328688A
(en)
|
1990-09-10 |
1994-07-12 |
Arch Development Corporation |
Recombinant herpes simplex viruses vaccines and methods
|
|
US5849571A
(en)
|
1990-10-10 |
1998-12-15 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Latency active herpes virus promoters and their use
|
|
US5342774A
(en)
|
1991-05-23 |
1994-08-30 |
Ludwig Institute For Cancer Research |
Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
|
|
US6235525B1
(en)
|
1991-05-23 |
2001-05-22 |
Ludwig Institute For Cancer Research |
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-3 and uses thereof
|
|
US5541104A
(en)
|
1991-05-23 |
1996-07-30 |
Ludwig Institute For Cancer Research |
Monoclonal antibodies which bind to tumor rejection antigen precursor mage-1
|
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
|
US5879934A
(en)
|
1992-07-31 |
1999-03-09 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Herpes simplex virus strains for gene transfer
|
|
JP3608788B2
(en)
|
1992-08-31 |
2005-01-12 |
ルドヴィグ・インスティテュート・フォー・キャンサー・リサーチ |
Isolated nonapeptides derived from the MAGE-3 gene and presented by HLA-A1 and their uses
|
|
US6222012B1
(en)
|
1992-08-31 |
2001-04-24 |
Ludwig Institute For Cancer Research |
Isolated nonapeptides presented by HLA molecules, and uses thereof
|
|
US5661033A
(en)
|
1992-11-25 |
1997-08-26 |
The Board Of Trustees Of The Leland Stanford Junior University |
Gene transfer using herpes virus vectors as a tool for neuroprotection
|
|
US5631237A
(en)
|
1992-12-22 |
1997-05-20 |
Dzau; Victor J. |
Method for producing in vivo delivery of therapeutic agents via liposomes
|
|
DE4311651A1
(en)
|
1993-04-08 |
1994-10-13 |
Boehringer Ingelheim Int |
Virus for the transport of foreign DNA into higher eukaryotic cells
|
|
US5834441A
(en)
|
1993-09-13 |
1998-11-10 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Adeno-associated viral (AAV) liposomes and methods related thereto
|
|
ES2216005T3
(en)
|
1993-11-09 |
2004-10-16 |
Targeted Genetics Corporation |
PRODUCTION OF ELEVATED TITLES OF RECOMBINANT AAV VECTORS.
|
|
FR2716682B1
(en)
|
1994-01-28 |
1996-04-26 |
Centre Nat Rech Scient |
Process for the preparation of recombinant adeno-associated viruses (AAV) and uses thereof.
|
|
FI963393A0
(en)
|
1994-03-01 |
1996-08-30 |
Ludwig Inst Cancer Res |
Determination of cancer conditions by MAGE gene expression
|
|
US6204059B1
(en)
|
1994-06-30 |
2001-03-20 |
University Of Pittsburgh |
AAV capsid vehicles for molecular transfer
|
|
US5856152A
(en)
|
1994-10-28 |
1999-01-05 |
The Trustees Of The University Of Pennsylvania |
Hybrid adenovirus-AAV vector and methods of use therefor
|
|
US5792453A
(en)
|
1995-02-28 |
1998-08-11 |
The Regents Of The University Of California |
Gene transfer-mediated angiogenesis therapy
|
|
US5707618A
(en)
|
1995-03-24 |
1998-01-13 |
Genzyme Corporation |
Adenovirus vectors for gene therapy
|
|
FR2732357B1
(en)
|
1995-03-31 |
1997-04-30 |
Rhone Poulenc Rorer Sa |
VIRAL VECTORS AND USE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS, ESPECIALLY RESTENOSIS
|
|
UA56132C2
(en)
|
1995-04-25 |
2003-05-15 |
Смітклайн Бічем Байолоджікалс С.А. |
Vaccine composition (variants), method for stabilizing qs21 providing resistance against hydrolysis (variants), method for manufacturing vaccine
|
|
US5773289A
(en)
|
1995-06-06 |
1998-06-30 |
University Of Pittsburgh |
AAV directed targeted integration
|
|
US5622856A
(en)
|
1995-08-03 |
1997-04-22 |
Avigen |
High efficiency helper system for AAV vector production
|
|
US5830727A
(en)
|
1995-11-18 |
1998-11-03 |
Human Gene Therapy Research Institute |
Herpes simplex virus amplicon mini-vector gene transfer system
|
|
GB9606293D0
(en)
|
1996-03-26 |
1996-05-29 |
William Harvey Research Limite |
Treatment of cancers and other tumours
|
|
US6251603B1
(en)
|
1996-10-03 |
2001-06-26 |
Ludwig Institute For Cancer Research |
Method for determining status of a cancerous condition by determining antibodies to NY-ESO-1 in a patient sample
|
|
WO1999029852A1
(en)
|
1997-12-05 |
1999-06-17 |
Medical College Of Georgia Research Institute, Inc. |
High-affinity tryptophan transporter
|
|
US6326507B1
(en)
|
1998-06-19 |
2001-12-04 |
Trustees Of Dartmouth College |
Therapeutic compounds and methods of use
|
|
US20100158871A1
(en)
*
|
1999-08-30 |
2010-06-24 |
David Stephen Terman |
Sickled erythrocytes with antitumor molecules induce tumoricidal effects
|
|
EP1606285A4
(en)
|
2003-03-27 |
2009-03-18 |
Lankenau Inst Medical Res |
IDO INHIBITORS AND METHODS OF USE THEREOF
|
|
CL2007002650A1
(en)
|
2006-09-19 |
2008-02-08 |
Incyte Corp |
COMPOUNDS DERIVED FROM HETEROCICLO N-HIDROXIAMINO; PHARMACEUTICAL COMPOSITION, USEFUL TO TREAT CANCER, VIRAL INFECTIONS AND NEURODEGENERATIVE DISORDERS BETWEEN OTHERS.
|
|
CA2727528A1
(en)
|
2007-06-14 |
2008-12-18 |
Osta Biotechnologies |
Heme-oxygenase inhibitors and use of the same in the treatment of cancer and diseases of the central nervous system
|
|
WO2010008427A1
(en)
|
2008-04-11 |
2010-01-21 |
Ludwig Institute For Cancer Research Ltd. |
Tryptophan catabolism in cancer treatment and diagnosis
|
|
HRP20141094T1
(en)
|
2008-07-08 |
2015-01-16 |
Incyte Corporation |
1,2,5-OXADIAZOLES AS INDOLAMINE 2,3-DIOXYGENASE INHIBITORS
|
|
CA2788284A1
(en)
*
|
2010-02-09 |
2011-08-18 |
Georgia Health Sciences University Research Institute, Inc. |
Alpha-methyl-tryptophan as an inhibitor of indoleamine dioxygenase
|